Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Reimann

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Clinical Orthopaedics and Related Research|February 1, 1989
Porous-coated knee arthroplasty. A case report concerning bone ingrowthB Hainau, I Reimann, S Dorph, et al.
Die Pharmazie|May 1, 1993
[The pharmacokinetics of a new anti-arrhythmic substance, Z-2-amino-5-chlorobenzophenoneamidinohydrazone (AWD-G256)]K Farker, L Henschel, J P Marschner, et al.
Nucleic Acids Research|April 2, 1999
Tissue-specific translational regulation of alternative rabbit 15-lipoxygenase mRNAs differing in their 3'-untranslated regionsB J Thiele, M Berger, A Huth, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Investigations into a new antiarrhythmic substance Z-2-amino-5-chlor-benzophenon-amidin-hydralazin in humansK Farker, L Henschel, J P Marschner, et al.
Biochimica Et Biophysica Acta|August 11, 1980
Identification of the major metabolite of prostacyclin and 6-ketoprostaglandin F1 alpha in manB Rosenkranz, C Fischer, I Reimann, et al.
British Medical Journal|April 28, 1979
Indomethacin increases plasma lithiumJ C Frölich, R Leftwich, M Ragheb, et al.
Archiv Fur Experimentelle Veterinarmedizin|January 1, 1990
[Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren]H Liebermann, I Reimann, T Bartels, et al.
Archiv Fur Experimentelle Veterinarmedizin|January 1, 1990
Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-KaufbeurenH Liebermann, U Holl, I Reimann, et al.
Artery|January 1, 1980
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in manB Rosenkranz, C Fischer, I Reimann, et al.
Die Pharmazie|May 1, 1993
[Hemodynamic effects and adverse effects of the anti-arrhythmic substance AWD-G256 in man]H Volkmann, G Dannberg, H Kühnert, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Clinical Orthopaedics and Related Research|February 1, 1989
Porous-coated knee arthroplasty. A case report concerning bone ingrowthB Hainau, I Reimann, S Dorph, et al.
Die Pharmazie|May 1, 1993
[The pharmacokinetics of a new anti-arrhythmic substance, Z-2-amino-5-chlorobenzophenoneamidinohydrazone (AWD-G256)]K Farker, L Henschel, J P Marschner, et al.
Nucleic Acids Research|April 2, 1999
Tissue-specific translational regulation of alternative rabbit 15-lipoxygenase mRNAs differing in their 3'-untranslated regionsB J Thiele, M Berger, A Huth, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Investigations into a new antiarrhythmic substance Z-2-amino-5-chlor-benzophenon-amidin-hydralazin in humansK Farker, L Henschel, J P Marschner, et al.
Biochimica Et Biophysica Acta|August 11, 1980
Identification of the major metabolite of prostacyclin and 6-ketoprostaglandin F1 alpha in manB Rosenkranz, C Fischer, I Reimann, et al.
British Medical Journal|April 28, 1979
Indomethacin increases plasma lithiumJ C Frölich, R Leftwich, M Ragheb, et al.
Archiv Fur Experimentelle Veterinarmedizin|January 1, 1990
[Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren]H Liebermann, I Reimann, T Bartels, et al.
Archiv Fur Experimentelle Veterinarmedizin|January 1, 1990
Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-KaufbeurenH Liebermann, U Holl, I Reimann, et al.
Artery|January 1, 1980
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in manB Rosenkranz, C Fischer, I Reimann, et al.
Die Pharmazie|May 1, 1993
[Hemodynamic effects and adverse effects of the anti-arrhythmic substance AWD-G256 in man]H Volkmann, G Dannberg, H Kühnert, et al.
Pageof 9